Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan for Preventing AF Recurrence After Ablation in Non-hypertensive Patients
NCT07910058Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Oct 2026
- Primary completion
- Mar 2029
01
Overview
A Phase 4 trial of sacubitril + valsartan in Atrial fibrillation (AFib), sponsored by Ruijin Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07910058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910058.